A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer.

Lorusso, V; Pollera, C F; Antimi, M; Luporini, G; Gridelli, C; Frassineti, G L; Oliva, C; Pacini, M; De Lena, M

Lorusso, V; Pollera, C F; Antimi, M; Luporini, G; Gridelli, C; Frassineti, G L; Oliva, C; Pacini, M; De Lena, M.

Affiliation

Lorusso V; Medical Oncology Division, Oncology Hospital, Bari, Italy.

Eur J Cancer ; 34(8): 1208-12, 1998 Jul.

Article in En | MEDLINE | ID: mdl-9849481

Subject(s)

Carcinoma, Transitional Cell/drug therapy; Cisplatin/therapeutic use; Deoxycytidine/analogs & derivatives; Urologic Neoplasms/drug therapy; Adult; Aged; Deoxycytidine/adverse effects; Deoxycytidine/therapeutic use; Female; Hematologic Diseases/chemically induced; Humans; Influenza, Human/chemically induced; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Gemcitabine

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Urologic Neoplasms / Cisplatin / Deoxycytidine Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 1998 Type: Article

Search on Google

XML

PubMed Links